Abstract:BACKGROUND: miRNA, as a biological marker, had more and more attention in recent years due to the important role it plays in cancer. Currently, there are extensive studies on miRNAs, among which miR-330-3p is reported to be implicated in the pathophysiological processes of various cancers. However, little progress has been made in the mechanism of miR-330-3p in gastric cancer.OBJECTIVE: To explore the expression and relevant mechanism of miR-330-3p and PRRX1 in gastric cancer (GC).METHODS: Forty-five GC patients (study group), from whom paired GC and paracancerous tissues were collected, and another 45 healthy subjects (control group) who underwent physical examination during the same period were enrolled. In addition, GC cells and human gastric mucosa cells were purchased, and miR-330-3p-mimics, miR-330-3p-inhibitor, miR-NC, si-PRRX1, and sh-PRRX1 were transfected into MKN45, SGC7901 cell. QRT-PCR was employed to assess the miR-330-3p and PRRX1 expressions in the samples, and the cell expressions of PRRX1, GSK-3β, p-GSK-3β, β-catenin, p-β-catenin, cyclin D1, N-cadherin, E-cadherin and vimentin were evaluated by Western blot (WB). MTT, Transwell and wound-healing experiments were adopted to detect cell proliferation, invasion and migration.RESULTS: MiR-330-3p was under-expressed, while PRRX1 was highly expressed in the serum of patients, both of which had an area under the curve (AUC) of more than 0.9. MiR-330-3p and PRRX1 were associated with tumor diameter, TNM staging, lymph node metastasis and differentiation of GC patients. Overexpression of miR-330-3p and inhibition of PRRX1 expression could suppress epithelial-mesenchymal transition (EMT), proliferation, invasion and apoptosis of cells. What is more, WB assay showed that overexpressed miR-330-3p and inhibited PRRX1 could inhibit the expression levels of p-GSK-3β, β-catenin, cyclin D1, N-cadherin and vimentin proteins, while elevating GSK-3β, p-β-catenin and E-cadherin protein expressions. Dual-luciferase reporter assay confirmed that there was a targeting relation between miR-330-3p and PRRX1. Furthermore, rescue experiments revealed that the cell proliferation, invasion, migration did not differ significantly between co-transfected miR-330-3p-mimics+sh-PRRX1, miR-330-3p-inhibitor+si-PRRX1 groups of MKN45 and SGC7901 and the miR-NC group (without transfected sequences).CONCLUSION: Overexpressed miR-330-3p can promote cell EMT, proliferation, invasion and apoptosis through inhibiting PRRX1-mediated Wnt/β-catenin signaling pathway, which is expected to be a potential therapeutic target for GC.

Inhibition of Migration and Invasion of Gastric Cancer Cells by Snail-Regulated Mir-375 Through Jak2 Targeting

Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2.

MiR-30 Suppresses Lung Cancer Cell 95D Epithelial Mesenchymal Transition and Invasion Through Targeted Regulating Snail.

Restoration Of Mir-1228*Expression Suppresses Epithelial-Mesenchymal Transition In Gastric Cancer

Retracted: Mir‐944 Inhibits Metastasis of Gastric Cancer by Preventing the Epithelial–mesenchymal Transition Via MACC1/Met/AKT Signaling

Mir-145 Suppresses Breast Cancer Cell Migration by Targeting FSCN-1 and Inhibiting Epithelial-Mesenchymal Transition.

MiR-375 Frequently Downregulated in Gastric Cancer Inhibits Cell Proliferation by Targeting JAK2

Mir-375 is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion Via Targeting Transcription Factor SP1

Mir-301a-5p/Scin Promotes Gastric Cancer Progression Via Regulating Stat3 And Nf-Kappa B Signaling

Mir-375 Inhibits the Invasion and Metastasis of Colorectal Cancer Via Targeting SP1 and Regulating EMT-associated Genes.

Mir-199A-3p Targets ETNK1 to Promote Invasion and Migration in Gastric Cancer Cells and is Associated with Poor Prognosis.

Mir-337-3p Inhibits Gastric Tumor Metastasis by Targeting ARHGAP10

Mir-140-3p is Involved in the Occurrence and Metastasis of Gastric Cancer by Regulating the Stability of FAM83B

Mir-345 Inhibits Migration and Stem-Like Cell Phenotype in Gastric Cancer Via Inactivation of Rac1 by Targeting EPS8

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

The Role of MiR-375 in Migration and Invasion of H.pylori-induced Gastric Cancer Cell Model

MiR-181d Inhibits Cell Proliferation and Metastasis Through PI3K/AKT Pathway in Gastric Cancer.

Mir-373 Suppresses Gastric Cancer Metastasis by Downregulating Vimentin.

High-Throughput Screening Identifies Mir-451 As a Pleiotropic Modulator That Suppresses Gastric Cancer Metastasis

Mir-192, A Prognostic Indicator, Targets the Slc39a6/Snail Pathway to Reduce Tumor Metastasis in Human Hepatocellular Carcinoma

Effects of miR-330-3p on Invasion, Migration and EMT of Gastric Cancer Cells by Targeting PRRX1-Mediated Wnt/β-Catenin Signaling Pathway